Virtu Financial’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-20,272
| Closed | -$686K | – | 1622 |
|
|
2024
Q4 | $686K | Sell |
20,272
-9,270
| -31% | -$334K | 0.04% | 410 |
|
|
2024
Q3 | $1.21M | Sell |
29,542
-22,958
| -44% | -$939K | 0.07% | 218 |
|
|
2024
Q2 | $2.02M | Buy |
+52,500
| New | +$2.21M | 0.14% | 138 |
|
|
2024
Q1 | – | Sell |
-9,154
| Closed | -$339K | – | 1675 |
|
|
2023
Q4 | $339K | Buy |
+9,154
| New | +$329K | 0.03% | 553 |
|
|
2023
Q1 | – | Sell |
-7,670
| Closed | -$269K | – | 1735 |
|
|
2022
Q4 | $269K | Sell |
7,670
-76,134
| -91% | -$2.54M | 0.04% | 540 |
|
|
2022
Q3 | $2.47M | Buy |
+83,804
| New | +$3.18M | 0.23% | 70 |
|
|
2021
Q4 | – | Sell |
-13,278
| Closed | -$634K | – | 1901 |
|
|
2021
Q3 | $634K | Buy |
+13,278
| New | +$667K | 0.06% | 362 |
|
|
2021
Q2 | – | Sell |
-8,756
| Closed | -$391K | – | 1723 |
|
|
2021
Q1 | $391K | Sell |
8,756
-12,738
| -59% | -$578K | 0.03% | 657 |
|
|
2020
Q4 | $989K | Sell |
21,494
-5,875
| -21% | -$270K | 0.11% | 227 |
|
|
2020
Q3 | $1.29M | Buy |
+27,369
| New | +$1.37M | 0.22% | 94 |
|
|
2019
Q4 | $694K | Buy |
+11,825
| New | +$658K | 0.07% | 316 |
|
|
2019
Q3 | – | Sell |
-4,516
| Closed | -$226K | – | 1566 |
|
|
2019
Q2 | $226K | Sell |
4,516
-6,190
| -58% | -$311K | 0.01% | 954 |
|
|
2019
Q1 | $559K | Sell |
10,706
-2,192
| -17% | -$110K | 0.03% | 508 |
|
|
2018
Q4 | $616K | Sell |
12,898
-8,086
| -39% | -$398K | 0.03% | 411 |
|
|
2018
Q3 | $1.05M | Sell |
20,984
-8,274
| -28% | -$420K | 0.06% | 314 |
|
|
2018
Q2 | $1.47M | Buy |
29,258
+15,980
| +120% | +$805K | 0.09% | 245 |
|
|
2018
Q1 | $648K | Sell |
13,278
-88,592
| -87% | -$4.13M | 0.03% | 561 |
|
|
2017
Q4 | $4.52M | Buy |
+101,870
| New | +$4.71M | 0.24% | 52 |
|
|
2017
Q2 | – | Sell |
-4,448
| Closed | -$234K | – | 436 |
|
|
2017
Q1 | $234K | Buy |
+4,448
| New | +$226K | 0.02% | 342 |
|
|
2016
Q1 | – | Sell |
-4,020
| Closed | -$203K | – | 441 |
|
|
2015
Q4 | $203K | Buy |
+4,020
| New | +$205K | 0.03% | 341 |
|
|
2013
Q3 | – | Sell |
-65,801
| Closed | -$4.11M | – | 297 |
|
|
2013
Q2 | $4.11M | Buy |
+65,801
| New | +$4.18M | 0.39% | 53 |
|
Other funds holding GSK
JEST
Virtu Financial's GSK Position: Q1 2025 in Review
Virtu Financial sold out of GSK (GSK) in Q1 2025, closing a stake of 20,272 shares — an estimated $686K sold.
Virtu Financial first reported a position in GSK in Q2 2013 and held it in 21 quarters. The position peaked at $4.52M in Q4 2017. 857 funds tracked by Wall St. Rank hold GSK as of Q1 2025.
- Virtu Financial reported no remaining GSK position as of Q1 2025 after selling out during the quarter.
- Virtu Financial sold 20,272 GSK shares in Q1 2025, an estimated $686K.
- Virtu Financial first reported a position in GSK in Q2 2013 and held it in 21 quarters.
- Virtu Financial's GSK position peaked at $4.52M in Q4 2017.
- 857 funds tracked by Wall St. Rank held GSK as of Q1 2025.
Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.